Multiple Sclerosis Trial, Recruiting (NCT05482906)

Multiple Sclerosis Trial, Recruiting NCT05482906 Sponsor: Nantes University Hospital Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT05482906 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with multiple sclerosis (MS), including relapsing-remitting or progressive types, based on recognised diagnostic guidelines
You are over 18 years old
You are currently receiving care at Nantes University Hospital or Rennes University Hospital
Your most recent disability score (a standard MS measure called EDSS) was between 0 and 6 before joining the trial (confirm with trial site)
You have not had an MS relapse (a flare-up of symptoms) in the past 3 months
You already have a spinal cord MRI scan planned as part of your usual medical care
Your MRI scan can be done within 4 months before or after a walking test as part of the study
You are covered by a French social security scheme

Who may not be able to join:

You need support on both sides (such as two walking aids or assistance from two people) to be able to walk
You are currently pregnant
You have said you do not wish to take part in the trial
You are under legal guardianship or a legal protection measure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 33 2 40 16 52 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05482906

Sponsor: Nantes University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 33 2 40 16 52 00

More information: https://clinicaltrials.gov/study/NCT05482906

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with multiple sclerosis (MS), including relapsing-remitting or progressive types, based on recognised diagnostic guidelines
You are over 18 years old
You are currently receiving care at Nantes University Hospital or Rennes University Hospital
Your most recent disability score (a standard MS measure called EDSS) was between 0 and 6 before joining the trial (confirm with trial site)
You have not had an MS relapse (a flare-up of symptoms) in the past 3 months
You already have a spinal cord MRI scan planned as part of your usual medical care
Your MRI scan can be done within 4 months before or after a walking test as part of the study
You are covered by a French social security scheme

Who may not be able to join:

You need support on both sides (such as two walking aids or assistance from two people) to be able to walk
You are currently pregnant
You have said you do not wish to take part in the trial
You are under legal guardianship or a legal protection measure

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nantes University Hospital

Registry

ClinicalTrials.gov

Start date

3 April 2023

Est. completion

30 April 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Clustering analyze based on IGP; Clustering analyze based on EDSS score; Clustering analyze based on MRI lesion load

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov